Mitsunori Kirihata Selected Research

Boron

2/2023	Multi-Targeted Neutron Capture Therapy Combined with an 18 kDa Translocator Protein-Targeted Boron Compound Is an Effective Strategy in a Rat Brain Tumor Model.
1/2022	Dodecaborate Conjugates Targeting Tumor Cell Overexpressing Translocator Protein for Boron Neutron Capture Therapy.
1/2022	Synthesis and cytotoxicity of the boron carrier pentagamaboronon-0-ol for boron neutron capture therapy against breast cancer.
12/2020	The Therapeutic Effects of Dodecaborate Containing Boronophenylalanine for Boron Neutron Capture Therapy in a Rat Brain Tumor Model.
1/2020	Synthesis and Evaluation of Dodecaboranethiol Containing Kojic Acid (KA-BSH) as a Novel Agent for Boron Neutron Capture Therapy.
8/2019	Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application.
7/2017	Practical calculation method to estimate the absolute boron concentration in tissues using 18F-FBPA PET.
1/2017	Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
1/2015	The Anti-Proliferative Effect of Boron Neutron Capture Therapy in a Prostate Cancer Xenograft Model.
3/2013	Effect of bevacizumab treatment on p-boronophenylalanine distribution in murine tumor.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mitsunori Kirihata Research Topics

Disease

33	Neoplasms (Cancer) 12/2023 - 01/2003
11	Glioma (Gliomas) 02/2023 - 12/2005
9	Brain Neoplasms (Brain Tumor) 02/2023 - 07/2006
6	Breast Neoplasms (Breast Cancer) 12/2023 - 08/2019
6	Glioblastoma (Glioblastoma Multiforme) 02/2023 - 11/2003
2	Clear Cell Sarcoma 12/2015 - 03/2013
1	Colonic Neoplasms (Colon Cancer) 10/2023
1	Colorectal Neoplasms (Colorectal Cancer) 10/2023
1	Neoplasm Metastasis (Metastasis) 12/2015
1	Prostatic Neoplasms (Prostate Cancer) 01/2015
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2015
1	Necrosis 09/2008
1	Hyperthermia 01/2003

Drug/Important Bio-Agent (IBA)

18	BoronIBA 02/2023 - 12/2005
9	SodiumIBA 03/2023 - 12/2005
6	Boron-10IBA 02/2023 - 05/2008
3	Monoclonal AntibodiesIBA 12/2023 - 05/2008
3	dodecaborateIBA 01/2022 - 12/2011
3	Therapeutic UsesIBA 12/2020 - 01/2011
3	Boron CompoundsIBA 09/2020 - 12/2005
3	Amino Acids FDA Link 01/2017 - 12/2011
2	CurcuminIBA 12/2023 - 10/2023
2	Bromodeoxyuridine (BrdU)IBA 03/2023 - 01/2003
2	Proteins (Proteins, Gene)FDA Link 02/2023 - 01/2022
2	LithiumIBA 01/2022 - 09/2020
2	Phenylalanine (L-Phenylalanine)FDA Link 12/2015 - 07/2009
2	Liposomes (Liposome)IBA 03/2009 - 05/2008
1	Dimenhydrinate (DMH)FDA LinkGeneric 10/2023
1	BoranesIBA 01/2022
1	polyarginineIBA 01/2022
1	Cell-Penetrating PeptidesIBA 01/2022
1	AnionsIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	AmidesIBA 12/2020
1	IsotopesIBA 01/2015
1	AcidsIBA 12/2014
1	Bevacizumab (Avastin)FDA Link 03/2013
1	4-boronophenylalanineIBA 03/2013
1	Angiogenesis InhibitorsIBA 03/2013
1	Temozolomide (Temodar)FDA LinkGeneric 12/2011
1	PolyaminesIBA 12/2011
1	GelatinIBA 01/2011
1	AntibodiesIBA 03/2009
1	FluoridesIBA 09/2008
1	Transferrin (beta 2 Transferrin)IBA 05/2008
1	Cytochalasin BIBA 01/2003
1	SuspensionsIBA 01/2003
1	Tirapazamine (SR 4233)IBA 01/2003

Therapy/Procedure

32	Boron Neutron Capture Therapy 03/2023 - 11/2003
8	Radiotherapy 01/2022 - 11/2003
3	Therapeutics 12/2023 - 01/2011
2	Neutron Capture Therapy 02/2023 - 01/2017
2	Drug Therapy (Chemotherapy) 07/2009 - 01/2009
2	Intraperitoneal Injections 07/2006 - 01/2003
1	Chemoprevention 10/2023
1	Intravenous Administration 02/2023
1	Craniotomy 11/2003
1	Oral Administration 01/2003